Subcutaneous immunoglobulin therapy in a patient with myopathic dropped head syndrome and common variable immunodeficiency

E. Rosato, I. Molinaro, S. Pisarri, F. Salsano

Article ID: 6266
Vol 25, Issue 4, 2011
DOI: https://doi.org/10.54517/jbrha6266
Received: 8 January 2012; Accepted: 8 January 2012; Available online: 8 January 2012; Issue release: 8 January 2012

Abstract

Prominent neck extension weakness is an uncommon clinical entity, also termed dropped-head syndrome, that may be part of a generalized neuromuscular disorder. We report here the case of a woman with dropped-head syndrome and pulmonary arterial hypertension secondary to systemic sclerosis. Subsequently, she developed common variable immunodeficiency and subcutaneous immunoglobulin therapy was started. After two months from the start of therapy we did not observe any improvement in the degree of flexion of the head, although the clinical examination shows an improvement in neck extensor muscle strength. Subcutaneous immunoglobulin therapy could be a possible therapeutic option for the treatment of myopathic neck extensor weakness


Keywords

dropped head syndrome;common variable immunodeficiency;subcutaneous immunoglobulins;systemic sclerosis


References

Supporting Agencies



Copyright (c) 2011 E. Rosato, I. Molinaro, S. Pisarri, F. Salsano




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).